許勝傑 ,Ph.D. 
單位: 長庚大學 
現職: 生物醫學系 助理教授 
聯絡地址: 333桃園市龜山區文化一路259號
電話: 03-2118800 轉 3690 傳真: 03-2118700
E-mail: schsu@mail.cgu.edu.tw
研究領域:
- 癌症
- 醫學之生化及分子生物
工作經歷: 98年3月-迄今 長庚大學生物醫學系
學歷: 國立陽明大學微生物及免疫學研究所博士
殊榮: Excellent Research Award, Liver Disease Prevention and Treatment Research Foundation, Taiwan, 2002.
代表論文:1. Hsu SC, Syu WJ, Sheen IJ, Liu HT, Jeng KS, Wu JC. Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications. 2002 Mar. Hepatology 35:665-72.
2. Lo HW, Hsu SC, Ali-Seyed M., Gunduz M, Xia W, Wei Y, Bartholomeusz G., Shih JY, Hung MC. Nuclear interaction of EGFR and STAT3 in the activation of iNOS/NO pathway. 2005 Jun. Cancer Cell 7(6):575-89.
3. Hsu SC and Hung MC. Characterization of a novel tripartite nuclear localization sequence in the EGFR family. 2007 Apr 6. J Biol. Chem. 282(14):10432-40.
4. Hsu SC, Miller SA, Wang Y, Hung MC. Nuclear EGFR is required for cisplatin resistance and DNA repair. Am. J. Transl. Res. 2009 Mar 8. 1(3):249-58.
5. Wu CP, Sim HM, Huang YH, Liu YC, Hsiao SH, Cheng HW, Li YQ, Ambudkar SV, Hsu SC. 2013 Feb. Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells. Biochem Pharmacol. 85:325-334.
所有論文著作一覽表
學會與認證:American Association for Cancer Research